SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 0.23 |
| Enterprise Value ($M) | 0.23 |
| Book Value ($M) | 0.00 |
| Book Value / Share | 0.00 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 23.84 |
| Operating Income | 1.87 |
| Net Income | 0.40 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -7.72 |
| Cash from Investing | -0.02 |
| Cash from Financing | 8.76 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | East West Capital, LLC | 3.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 252,656 | 795,353 | 31.77 | |
| 1,589,402 | 5,249,217 | 30.28 | |
| 314,062 | 959,632 | 32.73 | |
| 61,529,676 | 189,929,037 | 32.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BMRA – Biomerica, Inc. | BNTC – Benitec Biopharma Inc. |
| BOLT – Bolt Biotherapeutics, Inc. | BTAI – BioXcel Therapeutics, Inc. |
| BULL – Webull Corporation |
Financial data and stock pages provided by
Fintel.io